Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Shares Issued (2022 - 2025)

bioAffinity Technologies has reported Shares Issued over the past 3 years, most recently at $285.0 for Q4 2025.

  • Quarterly Shares Issued rose 100.02% to $285.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2025, up 420.09% year-over-year, with the annual reading at $4.8 million for FY2025, 251.09% up from the prior year.
  • Shares Issued was $285.0 for Q4 2025 at bioAffinity Technologies, down from $3.3 million in the prior quarter.
  • Over five years, Shares Issued peaked at $3.3 million in Q3 2025 and troughed at -$1.9 million in Q2 2024.
  • The 3-year median for Shares Issued is $193846.0 (2025), against an average of $203022.1.
  • The largest YoY upside for Shares Issued was 120.07% in 2025 against a maximum downside of 41.59% in 2025.
  • A 3-year view of Shares Issued shows it stood at -$1.7 million in 2022, then grew by 6.35% to -$1.6 million in 2024, then skyrocketed by 100.02% to $285.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Shares Issued are $285.0 (Q4 2025), $3.3 million (Q3 2025), and $387407.0 (Q2 2025).